Ovacome is very pleased that research findings show a CA125 blood test every four months with an annual transvaginal ultrasound improves the early diagnosis rate for women who are BRCA positive and so at higher risk of developing ovarian cancer. This takes us towards a positive case for an NHS ovarian cancer screening programme.
The news comes from the UK Familial Ovarian Cancer Screening Study (UKFOCSS) a long term study which includes Ovacome on its steering committee.
These results, published on 27 February, show a potential way for BRCA positive women to manage their risk of developing ovarian cancer while delaying risk-reducing surgery.
It is still not clear whether screening will improve cancer survival rates. The ongoing UK Collaborative Trial of Ovarian Cancer Screening Study (UKCTOCs) continues to research this.